Omnicell Inc (OMCL) - Financial and Strategic SWOT Analysis Review

Omnicell Inc (OMCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Omnicell Inc (Omnicell) develops and implements advanced medication management solutions. The company offers products and services, including medication and supply dispensing systems, robotics, software workflows, and operational analytics. Its EnlivenHealth brand, offers solutions for patient engagement and clinical workflows. Omnicell's products and services are utilized by healthcare providers across inpatient, outpatient, and retail settings. The company distributes its products and services directly to customers in the US and Canada; through direct sales teams in the UK, France, Germany, and Australia; and relying on distributors for the Middle East, Asia, and Latin America. Omnicell operates in the US, the UK, and Germany. Omnicell is headquartered in Fort Worth, Texas, the US.

Omnicell Inc Key Recent Developments

May 22,2025: Omnicell Expects Improved Profitability, Updates Second Quarter and Full Year 2025 Profit Outlook and Announces a New Stock Repurchase Program
May 14,2025: Omnicell Opens New Innovation Lab in Austin, Texas
Mar 24,2025: Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer
Mar 12,2025: Omnicell Announces Chief Financial Officer Transition

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note:Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Omnicell Inc - Key Facts
Omnicell Inc - Key Employees
Omnicell Inc - Key Employee Biographies
Omnicell Inc - Major Products and Services
Omnicell Inc - History
Omnicell Inc - Company Statement
Omnicell Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Omnicell Inc - Business Description
Other Break-up: Connected devices, software licenses, and other
Performance
Other Break-up: Consumables
Performance
Other Break-up: SaaS and Expert Service
Performance
Other Break-up: Technical services
Performance
Geographical Segment: Rest of World
Performance
Geographical Segment: United States
Performance
R&D Overview
Omnicell Inc - Corporate Strategy
Omnicell Inc - SWOT Analysis
SWOT Analysis - Overview
Omnicell Inc - Strengths
Omnicell Inc - Weaknesses
Omnicell Inc - Opportunities
Omnicell Inc - Threats
Omnicell Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Omnicell Inc, Recent Deals Summary
Section 4 – Company’s Recent Developments
May 22, 2025: Omnicell Expects Improved Profitability, Updates Second Quarter and Full Year 2025 Profit Outlook and Announces a New Stock Repurchase Program
May 14, 2025: Omnicell Opens New Innovation Lab in Austin, Texas
Mar 24, 2025: Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer
Mar 12, 2025: Omnicell Announces Chief Financial Officer Transition
Dec 09, 2024: Omnicell Unveils Omnisphere
Sep 25, 2024: Omnicell Hires Nnamdi Njoku as Executive Vice President and Chief Operating Officer
Aug 01, 2024: Omnicell Reports Q2 2024 Results
Aug 01, 2024: EnlivenHealth and Good Neighbor Pharmacy Seek to Empower Independent Pharmacies with New Clinical Scope of Practice and Reimbursement Solution
May 02, 2024: Omnicell Releases Q1 2024 Results
Feb 08, 2024: Omnicell Reports Results for Fiscal Year and Q4 Ended December 31, 2023
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Omnicell Inc, Key Facts
Omnicell Inc, Key Employees
Omnicell Inc, Key Employee Biographies
Omnicell Inc, Major Products and Services
Omnicell Inc, History
Omnicell Inc, Other Locations
Omnicell Inc, Subsidiaries
Omnicell Inc, Key Competitors
Omnicell Inc, Ratios based on current share price
Omnicell Inc, Annual Ratios
Omnicell Inc, Annual Ratios (Cont...1)
Omnicell Inc, Annual Ratios (Cont...2)
Omnicell Inc, Interim Ratios
Omnicell Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Omnicell Inc, Performance Chart (2020 - 2024)
Omnicell Inc, Ratio Charts

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings